Ageing Science

What is Biological Ageing?

Biological ageing is broadly defined as the time-dependent functional decline that affects most living organisms. It is characterized by the progressive accumulation of damage at the molecular, cellular, and tissue levels. This accumulation eventually leads to a loss of physiological integrity, impaired function, and increased vulnerability to death.

Major Categories of Research

Modern geroscience—the study of the biology of ageing—typically categorizes ageing processes into several key "hallmarks" or pillars. While the exact list evolves, major areas of study include:

• Genomic Instability: The accumulation of genetic damage over time.
• Telomere Attrition: The shortening of the protective caps on chromosomes.
• Epigenetic Alterations: Changes in gene expression that do not involve changes to the underlying DNA sequence.
• Loss of Proteostasis: The failure of cellular machinery to maintain healthy protein function.
• Mitochondrial Dysfunction: A decline in the energy-producing efficiency of cells.
• Cellular Senescence: The accumulation of cells that have stopped dividing but do not die, often releasing inflammatory signals.

Knowns vs. Unknowns

While we have identified these mechanisms, much remains unknown.

• Driver vs. Passenger: It is often unclear which changes are the causes of ageing and which are merely consequences of it.
• Interconnectivity: These hallmarks are deeply interconnected; affecting one often influences others.
• Translation to Humans: Much of our current understanding comes from short-lived model organisms like yeast, worms (C. elegans), and mice. Translating these findings to human biology is a complex and ongoing challenge.

Common Mistakes in Ageing Interpretation

• Treating correlation as causation: Not every age-associated change drives ageing. See Damage Accumulation vs Programmed Ageing and Why Ageing Is Not a Single Process.
• Assuming one mechanism explains all decline: Mechanisms interact and differ by tissue and timeframe. See Hallmarks of Ageing and Biological Variability in Ageing.
• Overgeneralizing model-organism results: Animal and cell findings are useful, but human translation is complex. See Species Differences in Ageing Rates and How to Evaluate Longevity Evidence.

Browse by Topic

Foundations

• What Is Ageing? Defines ageing as a biological process across systems and timescales, and distinguishes chronological age from biological ageing dynamics.
• Ageing vs. Disease Clarifies where normal age-related change ends and pathology begins, a key distinction for both research claims and clinical framing.
• Why Ageing Is Not a Single Process Shows how molecular, cellular, and systemic factors jointly shape decline, reinforcing the need for multi-mechanism interpretation.
• Biological Variability in Ageing Explains why people of the same age can show different functional and molecular trajectories across organ systems.
• Cellular Heterogeneity in Ageing Tissues Explains why ageing tissues become mosaics of changing cell types, cell states, clones, and local microenvironments.

Mechanisms and Hallmarks

• Hallmarks of Ageing Introduces the hallmark framework, how hallmark processes interact, and why no single hallmark fully explains ageing outcomes.
• Epigenetic Dysregulation and Ageing Explains how age-related methylation and chromatin changes relate to ageing biology, and why epigenetic clocks likely reflect several overlapping mechanisms rather than one single process.
• Chromatin Remodelling in Ageing Examines how heterochromatin loss, histone changes, and transcriptional drift fit into the wider biology of ageing and genomic maintenance.
• DNA Damage Response and Ageing Explains how cells detect and repair genome damage, and why persistent damage signalling links genomic instability to senescence, stem-cell decline, and wider ageing biology.
• Stem Cell Exhaustion as a Hallmark of Ageing Explains how age-related declines in stem-cell function, self-renewal, and niche support can limit tissue maintenance and repair across different organs.
• Intercellular Communication and Ageing Explains how systemic signals, circulating factors, and extracellular vesicles can transmit age-related effects between cells, tissues, and organs.
• The TOR/mTOR Pathway and Ageing Covers how nutrient-sensing pathways influence growth, repair, and lifespan-related biology in preclinical and translational contexts.
• Nutrient-Sensing Pathways in Ageing Explains how AMPK and insulin/IGF-1 signalling fit into the wider nutrient-sensing network and why they are usually interpreted alongside mTOR rather than in isolation.
• Sirtuins and Ageing (Mechanisms and Research Landscape) Explains how the sirtuin family connects NAD+ sensing to chromatin regulation, mitochondrial control, and the mixed lifespan evidence across model systems.
• NAD Metabolism and Ageing Explains how NAD+ supports redox balance, DNA repair, and sirtuin-related signaling, and why age-related NAD decline is studied as part of a wider metabolic and stress-response network.
• Proteostasis and Ageing Explains how cells maintain protein quality through chaperones, degradation systems, and unfolded protein responses, and why this network weakens with age.
• Loss of Proteostasis vs Genomic Instability Compares two core hallmarks of ageing, showing where genome maintenance and protein quality control diverge, overlap, and resist simple ranking.
• Glycation and Advanced Glycation End-Products (AGEs) Explains how non-enzymatic sugar-derived damage accumulates in long-lived tissues, alters matrix mechanics, and connects to inflammatory signaling in ageing biology.
• Extracellular Matrix Stiffening and Ageing Explains how age-related matrix remodelling, crosslinking, fibrosis, and mechanotransduction can shape tissue stiffness and cellular behaviour.
• Mitochondrial Function and Ageing Reviews energy metabolism, mitochondrial quality control, and how mitochondrial changes relate to functional decline.
• Mitochondrial DNA Mutations and Ageing Explains how mtDNA mutations, heteroplasmy, and clonal expansion are interpreted in ageing biology across animal models and human tissues.

Cellular Senescence

• Senescence vs Apoptosis Differentiates two major cell-fate programs and why this distinction matters for tissue health, inflammation, and cancer risk.
• What Triggers Cellular Senescence? Maps major triggers including DNA damage, stress signaling, and telomere erosion, and the contexts where senescence may be adaptive or harmful.
• The SASP Explained Describes the senescence-associated secretory phenotype, its inflammatory effects, and why context determines its net biological impact.
• Senescent Cells and Cancer Examines dual roles of senescence in tumor suppression and tumor-promoting microenvironments across stages of disease.
• Immune Clearance of Senescent Cells Explores how immune surveillance removes senescent cells, how this process weakens with age, and implications for intervention research.

Theories and Models

• Why Organisms Age Compares leading explanatory models, including damage accumulation and evolutionary tradeoffs, with attention to current evidence limits.
• Evolutionary Theories of Ageing Summarizes antagonistic pleiotropy, disposable soma, and related theories to explain why ageing persists from an evolutionary perspective.
• Damage Accumulation vs Programmed Ageing Explores competing and overlapping models of ageing causation, including how each model interprets intervention effects.
• Species Differences in Ageing Rates Examines how lifespan and ageing pace differ across species, and what comparative biology can and cannot tell us about humans.
• Cellular Reprogramming and Age Reversal Explains the promise and current limits of reprogramming approaches, including safety and translation challenges.

Frequently Asked Questions

Is ageing a single biological process?

Ageing is understood as a set of interacting processes across molecular, cellular, tissue, and system levels rather than one mechanism.

Are age-related changes always diseases?

Ageing raises disease risk but is not identical to any single diagnosis. Distinguishing background ageing from pathology is important for interpretation.

Can findings from model organisms be directly applied to humans?

Model organisms provide key insights, but direct translation to human ageing is often uncertain and requires careful validation.